The stock of TESARO Inc (NASDAQ:TSRO) hit a new 52-week high and has $159.10 target or 32.00% above today’s $120.53 share price. The 5 months bullish chart indicates low risk for the $6.15B company. The 1-year high was reported on Oct, 10 by Barchart.com. If the $159.10 price target is reached, the company will be worth $1.97 billion more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 2.38M shares traded hands or 118.35% up from the average. TESARO Inc (NASDAQ:TSRO) has risen 117.06% since March 7, 2016 and is uptrending. It has outperformed by 109.46% the S&P500.
Analysts await TESARO Inc (NASDAQ:TSRO) to report earnings on November, 3. They expect $-1.92 earnings per share, down 15.66% or $0.26 from last year’s $-1.66 per share. After $-1.28 actual earnings per share reported by TESARO Inc for the previous quarter, Wall Street now forecasts 50.00% negative EPS growth.
TESARO Inc (NASDAQ:TSRO) Ratings Coverage
Out of 12 analysts covering Tesaro Inc (NASDAQ:TSRO), 10 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 83% are positive. Tesaro Inc has been the topic of 18 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The stock of TESARO Inc (NASDAQ:TSRO) earned “Outperform” rating by Leerink Swann on Monday, August 24. The firm has “Sell” rating given on Tuesday, September 1 by Zacks. The stock of TESARO Inc (NASDAQ:TSRO) earned “Buy” rating by Citigroup on Thursday, March 17. The company was initiated on Friday, August 12 by RBC Capital Markets. The rating was maintained by FBR Capital on Monday, October 10 with “Outperform”. Robert W. Baird initiated the stock with “Outperform” rating in Tuesday, July 19 report. Mizuho maintained TESARO Inc (NASDAQ:TSRO) on Friday, August 5 with “Buy” rating. Bank of America initiated TESARO Inc (NASDAQ:TSRO) on Tuesday, August 30 with “Neutral” rating. FBR Capital maintained TESARO Inc (NASDAQ:TSRO) rating on Wednesday, June 29. FBR Capital has “Outperform” rating and $93 price target. The stock of TESARO Inc (NASDAQ:TSRO) earned “Outperform” rating by RBC Capital Markets on Monday, October 10.
According to Zacks Investment Research, “Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company’s product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer and other cancer indications, and Niraparib, an orally active and potent poly (ADP-ribose) polymerase inhibitor for the treatment of patients with solid tumors. Tesaro, Inc. is based in Waltham, Massachusetts.”
Insitutional Activity: The institutional sentiment increased to 1.55 in 2016 Q2. Its up 0.32, from 1.23 in 2016Q1. The ratio improved, as 24 funds sold all TESARO Inc shares owned while 36 reduced positions. 34 funds bought stakes while 59 increased positions. They now own 44.90 million shares or 3.32% less from 46.44 million shares in 2016Q1.
D E Shaw Inc has 0.03% invested in the company for 187,198 shares. Raymond James Fincl Svcs Incorporated accumulated 5,640 shares or 0% of the stock. The Massachusetts-based Cormorant Asset Mngmt Ltd Company has invested 4.33% in TESARO Inc (NASDAQ:TSRO). Teacher Retirement Systems Of Texas last reported 3,954 shares in the company. Tiaa Cref Inv Mgmt holds 85,908 shares or 0.01% of its portfolio. Acuta Ltd last reported 30,000 shares in the company. The Connecticut-based Oracle Investment Management has invested 13.05% in TESARO Inc (NASDAQ:TSRO). Moreover, Smith Asset Gru Inc Lp has 0.01% invested in TESARO Inc (NASDAQ:TSRO) for 4,830 shares. California Pub Employees Retirement Sys holds 0.01% of its portfolio in TESARO Inc (NASDAQ:TSRO) for 56,200 shares. Tudor Investment Corporation Et Al has 4,851 shares for 0.01% of their US portfolio. Blackrock Grp reported 94,658 shares or 0% of all its holdings. Jefferies Grp Inc Ltd Liability Company last reported 0% of its portfolio in the stock. Blackrock Institutional Trust Na accumulated 719,297 shares or 0.01% of the stock. The New York-based Bamco Ny has invested 0% in TESARO Inc (NASDAQ:TSRO). The Connecticut-based Columbus Circle has invested 0.08% in TESARO Inc (NASDAQ:TSRO).
Insider Transactions: Since June 10, 2016, the stock had 0 insider purchases, and 5 sales for $4.39 million net activity. 7,000 shares with value of $619,803 were sold by English Edward C on Thursday, September 8. $2.51M worth of TESARO Inc (NASDAQ:TSRO) was sold by Hanke Jeffrey H.. The insider Huber Martin H. Jr. sold 408 shares worth $44,113.
More recent TESARO Inc (NASDAQ:TSRO) news were published by: Benzinga.com which released: “Benzinga’s Volume Movers” on October 10, 2016. Also Rttnews.com published the news titled: “Tesaro Inc. (TSRO) Has Jumped To A New High On Phase 3 Study Results” on October 10, 2016. Schaeffersresearch.com‘s news article titled: “Analyst Upgrades: Deere & Company, Panera Bread Co, and TESARO Inc” with publication date: October 10, 2016 was also an interesting one.
TSRO Company Profile
TESARO, Inc. (TESARO), incorporated on March 26, 2010, is an oncology-focused biopharmaceutical company. The Firm acquires, in-licenses and develops oncology product candidates. The Firm operates in business of developing and commercializing oncology-focused therapeutics segment. The Firm has in-licensed and are developing oncology-related product candidates, including intravenous (IV) rolapitant and niraparib, as well as product candidates under its immuno-oncology platform.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.